Headache medicine · 2026

Migraine treatment,
CGRP, Botox, neuromodulation.

NMPA-approved CGRP antagonists (erenumab, galcanezumab, fremanezumab) at 40–60% off US pricing. Botox for chronic migraine, occipital and sphenopalatine nerve blocks, neuromodulation, and acupuncture.

NMPA

CGRP approved

Erenumab, galcanezumab, fremanezumab + small-molecule gepants

NMPA approvals

$280–680 / mo

CGRP mAb pricing

vs $700–$900 / month in the US

NMPA listings

Class A

Headache centres

Tiantan, Huashan, Xuanwu neurology

NHC ratings

Botox

Chronic migraine

31-injection PREEMPT protocol; NMPA-approved

Centre programs

Acupuncture

Cochrane-supported

Modest evidence for migraine prevention

Cochrane 2016

Bilingual

Headache plan

Diary, plan, and home-team handover

Service standard

Tiers & pricing

Six tiers, transparent pricing.

Step 1

Headache assessment

Headache history, ICHD-3 classification, MIDAS / HIT-6, MRI / MRA if indicated.

$650–1,400

Preventive

CGRP mAb (monthly / quarterly)

Erenumab (Aimovig), galcanezumab (Emgality), fremanezumab (Ajovy), eptinezumab IV.

$280–680 / month

Acute / preventive

Gepants (oral CGRP antagonists)

Rimegepant, ubrogepant, zavegepant nasal — for acute or preventive use depending on agent.

$8–35 / dose

PREEMPT protocol

Botox for chronic migraine

31-site injection q12 weeks. NMPA-approved for chronic migraine ≥ 15 days/month.

$650–1,400 / round

Interventional

Nerve blocks

Greater occipital, lesser occipital, supraorbital, sphenopalatine ganglion blocks.

$280–680 / level

Adjunctive

Acupuncture / TCM

Migraine prevention with modest published evidence; offered alongside Western prevention.

$45–95 / session

Top hospitals

Six centres
open to international patients.

Beijing

Tiantan Hospital Neurology + Headache 天坛医院

China's largest neuroscience centre · large headache program · trial site

Shanghai

Huashan Hospital Neurology 华山医院

Class A · neurology reference · headache and migraine specialty

Beijing

Xuanwu Hospital Neurology 宣武医院

Class A · large neurology · stroke and headache

Beijing

PUMC Neurology 北京协和医院

Academic neurology · diagnostic excellence · rare headache syndromes

Multi-city

United Family Hospitals 和睦家

JCI · expat-focused neurology · routine migraine follow-up

Multi-city

TCM specialty hospitals 中医医院

Acupuncture for migraine · drug-interaction screened · adjunctive

FAQ

Frequently asked questions.

Why China for migraine treatment?
Three reasons: (1) NMPA has approved all four CGRP monoclonal antibodies (erenumab, galcanezumab, fremanezumab, eptinezumab) plus gepants (rimegepant, ubrogepant, zavegepant nasal) at NMPA-listed prices substantially below US; (2) Botox PREEMPT protocol for chronic migraine is widely available; (3) integrative acupuncture has Cochrane-reviewed modest evidence for migraine prevention and is offered alongside Western prevention without dilution.
What does a comprehensive headache workup include?
Standard 1–2 day pathway: detailed headache history; ICHD-3 classification (migraine with / without aura, chronic migraine, tension-type, cluster, medication-overuse, secondary headache); red-flag screen; brain MRI ± MRA if SNOOP red flags; ophthalmology consult if IIH or aura concern; MIDAS, HIT-6, headache diary review; comprehensive medication review including over-the-counter analgesic and caffeine intake. Bilingual final plan including acute, preventive and lifestyle approaches.
What about CGRP-targeted therapy?
Four monoclonal antibodies available at NMPA-listed pricing: erenumab (Aimovig, anti-CGRP receptor) ~$280–$420/month; galcanezumab (Emgality, anti-CGRP) ~$320–$480/month; fremanezumab (Ajovy, anti-CGRP) ~$360–$520/month for monthly or $720–$1,200 quarterly; eptinezumab (Vyepti, IV) ~$1,800–$2,800 quarterly. Oral gepants for acute (rimegepant, ubrogepant) and preventive (rimegepant, atogepant) at substantially lower per-dose costs than US triptan rebates. Long-term continuity requires home-physician handover.
What about Botox for chronic migraine?
PREEMPT protocol: 31-injection technique across forehead, temple, occiput, neck, shoulder muscles, q12 weeks, indicated for chronic migraine (≥ 15 headache days/month with ≥ 8 migraine days). NMPA-approved 2020. Indicative cost $650–$1,400 per round (drug + administration) vs $1,200–$2,200 in the US. Effect typically seen by round 2 (week 24). Combined Botox + CGRP mAb is increasingly common for refractory chronic migraine.
What about device-based and neuromodulation options?
External trigeminal nerve stimulation (Cefaly) — FDA / NMPA cleared for acute and preventive migraine, available for at-home use. Transcranial magnetic stimulation (sTMS, sTMSmini): NICE-approved for migraine; limited Chinese availability. Vagus nerve stimulation (gammaCore): for cluster and migraine; limited Chinese availability. Surgical neuromodulation (occipital nerve stimulation): for highly refractory cases at specialist centres.
What about chronic medication overuse and detox?
Medication-overuse headache (MOH) is a major contributor to chronic daily headache and is treated by structured withdrawal of overused acute medication, bridge therapy with steroid taper or DHE infusion, and initiation of preventive therapy. Class A neurology centres run inpatient withdrawal programs for severe MOH ($2,500–$5,500 per 5–7 day admission).

Send your headache diary
for a written plan.

Share your headache history, current medication and ICHD pattern. We return a written plan from a partner headache specialist — including CGRP, Botox, gepant or acupuncture options matched to your phenotype.

This page is for general information only and does not constitute medical advice. Sudden severe ('thunderclap') headache, headache with neurological deficit, or headache with fever and neck stiffness are medical emergencies — present to your nearest ED.